Sanofi Says Mylan Infringing 18 Insulin Patents
Sanofi filed a patent infringement suit Tuesday in New Jersey federal court alleging Mylan's planned generic version of Sanofi's insulin pen, Lantus, infringes 18 of its patents....To view the full article, register now.
Already a subscriber? Click here to view full article